← All organizations

Rhodes Pharmaceuticals, L.P.

For profitWebsite ↗

Also known as: Rhodes Phamaceuticals, L.P. | RHODES PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Nov 4, 2025

Defunct as of Oct 1, 2019

Timeline

2000s

Jun 1, 2007
Rhodes Pharmaceuticals, L.P.— Founded

2010s

Apr 17, 2015
methylphenidate— NDA Secondary Org
Oct 1, 2019
Rhodes Pharmaceuticals, L.P.— Defunct

2020s

Aug 25, 2023
lisdexamfetamine— Marketing Organization

Drugs by trial phase (3 distinct, 11 trials)

Phase 4 (1 own, 0 via acquisition)

methylphenidate

Phase 3 (1 own, 0 via acquisition)

lisdexamfetamine

Phase 2 (1 own, 0 via acquisition)

pg101

Indications

Studied for

Recent trials (14)

NCT02677519Lead sponsorPhase 4Sep 1, 2016
NCT02683265Lead sponsorPhase 4Mar 1, 2016
NCT02470234Study directorPhase 4Feb 1, 2016
NCT02470234Lead sponsorPhase 4Feb 1, 2016
NCT02555150Lead sponsorPhase 3Sep 1, 2015
NCT02225639Lead sponsorPhase 3Aug 1, 2014
NCT02168127Lead sponsorPhase 3May 1, 2014
NCT02139111Lead sponsorPhase 3Apr 1, 2014
NCT02139124Lead sponsorPhase 3Apr 1, 2014
NCT02078661Lead sponsorPhase 1/Phase 2Dec 1, 2013
NCT01269463Lead sponsorPhase 3Dec 1, 2010
NCT01269463Study chairPhase 3Dec 1, 2010
NCT01239030Study chairPhase 3Nov 1, 2010
NCT01239030Lead sponsorPhase 3Nov 1, 2010

Details

Founded: Coventry, RI, US Jun 1, 2007
Last known activity: Nov 4, 2025

Notes

Owned by Sackler family